Stock Analiz

BSX vs RMD stock comparison

Boston Scientific vs. Resmed · data as of November 13, 2026

Boston Scientific (BSX) has a market value of about $64.3B, Resmed (RMD) about $33.7B. Over their latest twelve months Boston Scientific had revenue of $21.1B and Resmed $5.7B.

On our five checks Resmed scores higher: 4.2 out of 5 (excellent) against 3.0 (average).

By area, the stronger company is Boston Scientific on future growth; Resmed on track record; Resmed on financial health; Resmed on shareholder returns.

Boston Scientific is cheaper on earnings (P/E 18.8 vs. 21.8).

Boston Scientific leads on 12 of the compared lines and Resmed on 10.

Side by side

BSXRMD
Size and price
Market cap$64.3B$33.7B
Share price$44.34$239.53
Score
Overall score (of 5)3.04.2
Value33
Future growth54
Track record25
Financial health45
Shareholder returns14
Valuation
P/E (TTM)18.821.8
Forward P/E14.418.9
Price / free cash flow19.320.9
Price / sales3.15.9
EV / EBITDA14.115.9
PEG—0.83
DCF value vs. price−58%−28%
Business
Revenue$21.1B$5.7B
Net income$3.5B$1.6B
Free cash flow$3.3B$1.6B
Net margin16.6%27.8%
Gross margin (5-yr avg.)68.9%57.9%
ROIC (5-yr avg.)5.9%18.9%
Growth
Revenue growth (1 yr)19.9%9.8%
Revenue growth (5 yrs, per year)15.2%12.1%
EPS growth (5 yrs, per year)—26.3%
Balance sheet and payouts
Net cash (cash minus debt)-$11.3B$400M
Dividend yieldNone1.10%
Shareholder yield0.0%3.2%
Analysts
Upside to average target+12%+10%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: BSX TTM to September 30, 2026, RMD TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Boston Scientific or Resmed?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) Resmed scores 4.2 out of 5 and Boston Scientific 3.0; the table shows where each one is stronger.

Is Boston Scientific cheaper than Resmed?

On trailing earnings, Boston Scientific trades at a P/E of 18.8 and Resmed at 21.8, so Boston Scientific is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Boston Scientific or Resmed?

Over five years Boston Scientific grew revenue about 15.2% a year and Resmed about 12.1% a year.

Which pays a higher dividend?

Boston Scientific yields nothing (no dividend) and Resmed 1.10%.

Full Boston Scientific analysis → Full Resmed analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.